Pharnext SAS Revenue and Competitors
Estimated Revenue & Valuation
- Pharnext SAS's estimated annual revenue is currently $6M per year.
- Pharnext SAS's estimated revenue per employee is $155,000
Employee Data
- Pharnext SAS has 39 Employees.
- Pharnext SAS grew their employee count by -13% last year.
Pharnext SAS's People
| Name | Title | Email/Phone |
|---|
Pharnext SAS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 81 | -5% | N/A | N/A |
#2 | $19.5M | 126 | -2% | N/A | N/A |
#3 | $36.3M | 234 | 22% | N/A | N/A |
#4 | $19.7M | 127 | -17% | N/A | N/A |
#5 | $14.3M | 92 | 0% | $179.5M | N/A |
#6 | $49.4M | 208 | -8% | €201.1M | N/A |
#7 | $44.5M | 287 | -3% | N/A | N/A |
#8 | $7.6M | 49 | N/A | N/A | N/A |
#9 | $6.4M | 41 | N/A | N/A | N/A |
#10 | $17.2M | 111 | -15% | N/A | N/A |
What Is Pharnext SAS?
Pharnext is an advanced, clinical-stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext has two lead products in clinical development. PXT3003 is currently in an international Phase 3 trial for the treatment of Charcot-Marie-Tooth disease type 1A and benefits from orphan drug status in Europe and the United States. PXT864 has generated positive Phase 2 results in Alzheimer's disease. Pharnext is the pioneer of a new drug discovery paradigm: PLEOTHERAPYâ„¢. The Company identifies and develops synergic combinations of repositioned drugs at low dose. These PLEODRUGâ„¢ offer several key advantages: efficacy, safety and intellectual property including several product or composition of matter patents already granted. The Company is supported by a world-class scientific team. The company Pharnext is listed on Euronext Alternext Stock Exchange in Paris (ISIN code: FR00111911287). For more information, visit www.pharnext.com
keywords:N/A
N/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 39 | -7% | $11.2M |
#2 | $6.6M | 39 | 3% | N/A |
#3 | $6.3M | 39 | N/A | N/A |
#4 | $9.5M | 39 | 8% | N/A |
#5 | $6.3M | 39 | -9% | N/A |